DHTKD1 and Familial prostate cancer: Besides it, the data demonstrated that introduction of WPRE did not significantly affect the restricted expression of E1A driven by DD3 promoter in prostate cancer cells, providing a strong piece of evidence supporting that WPRE is a promising candidate for constructing an oncolytic adenovirus to target prostate cancer cells.